LUZ Establishes Linguistic Validation Business Unit
Life science translation provider builds expert team to support patient-reported outcome measures.
San Francisco, CA, September 11, 2013 --(PR.com)-- LUZ, Inc., provider of life science translations services, today announced the launch of a Linguistic Validation business unit to meet a growing demand for patient-reported outcomes (PROs). The new business unit utilizes LUZ’s existing core competencies while delivering dedicated conceptual equivalence and readability services to ensure compliance with industry standards and best practices according to the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).
Creating the new business unit strengthens LUZ’s position as a leading provider of life science translation solutions and offers distinctive core capabilities in a highly specialized service area.
“We’ve assembled an outstanding global team of translators and subject-matter experts,” said Waldemar Frank, LUZ’s Director of Integrated Client Solutions. “LUZ has always focused on quality and a strong client service experience, and this new business unit will enable both our clients and LUZ to collaborate more effectively to address a very specialized need. By establishing internal and dedicated capabilities for validation services, we will be able to deliver more responsive and cost-effective services as well as further improve the quality of instruments and the underlying collected data. This will put us in a unique position in our industry since many translation service providers tend to outsource such specialty services to niche players due to the specific skills and knowledge involved.”
LUZ has successfully provided linguistic validation services for rare languages and diverse patient populations for a wide range of medical research areas including neurology, immunology, endocrinology, oncology, pediatrics, rheumatology, and more.
About LUZ, Inc.
LUZ, Inc. was founded in 1994 on a straightforward business philosophy to provide high-quality translation services and solutions to life science companies worldwide. LUZ is certified as a women- and minority-owned business and maintains certifications to ISO 9001, ISO 13485, and EN 15038. Through its enterprise-level AURORA technology platform and regional offices, LUZ delivers peace of mind to corporate life science clients across the globe.
To find out more, please visit www.luz.com.
Creating the new business unit strengthens LUZ’s position as a leading provider of life science translation solutions and offers distinctive core capabilities in a highly specialized service area.
“We’ve assembled an outstanding global team of translators and subject-matter experts,” said Waldemar Frank, LUZ’s Director of Integrated Client Solutions. “LUZ has always focused on quality and a strong client service experience, and this new business unit will enable both our clients and LUZ to collaborate more effectively to address a very specialized need. By establishing internal and dedicated capabilities for validation services, we will be able to deliver more responsive and cost-effective services as well as further improve the quality of instruments and the underlying collected data. This will put us in a unique position in our industry since many translation service providers tend to outsource such specialty services to niche players due to the specific skills and knowledge involved.”
LUZ has successfully provided linguistic validation services for rare languages and diverse patient populations for a wide range of medical research areas including neurology, immunology, endocrinology, oncology, pediatrics, rheumatology, and more.
About LUZ, Inc.
LUZ, Inc. was founded in 1994 on a straightforward business philosophy to provide high-quality translation services and solutions to life science companies worldwide. LUZ is certified as a women- and minority-owned business and maintains certifications to ISO 9001, ISO 13485, and EN 15038. Through its enterprise-level AURORA technology platform and regional offices, LUZ delivers peace of mind to corporate life science clients across the globe.
To find out more, please visit www.luz.com.
Contact
LUZ, Inc.
Diane DiPrima
415.981.5890 ext. 136
www.luz.com
Diane DiPrima
415.981.5890 ext. 136
www.luz.com
Contact
Categories